Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $3.9552W HIGH $6.50
Volume
450.36 K
Value Traded
7.98 M
Short % Float
6.47%
Days to Cover
6.1
+2.64%Week
-11.57%1 Month
-9.34%3 Month
-5.86%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
412.26 M
EPS (TTM)
0.45
P/E Ratio
10.25
Ent. Value
389.50 M
Total Shares
88.43 M
Float Shares
66.92 M
Insiders
24.36%
Institutions
60.82%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
SRTA Catalyst Timeline
Dated clinical, regulatory and corporate events for Strata Critical Medical, Inc. Class A Common Stock
Past FDA Catalysts and PDUFA Decisions
How SRTA actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Strata Critical Medical, Inc. Class A is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every SRTA program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Love ReginaldDirector | Sell | -5,091 146,481 held | $5.75 | 08/10/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in SRTA
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in SRTA for Q2 2026. | ||||
SRTA Institutional Ownership Trends
SRTA Short Interest
Shares sold short, counted twice a month.
6.47%
Short % of Float
of tradable shares sold short
4.3M
Shares Sold Short
-0.6% vs prior count
6.1 High
Days to Cover
trading days of normal volume to buy every short share back
713.3K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How SRTA ranks across every disease it competes in
Competitive Position is a premium feature
See how SRTA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialSRTA News
-SRTA
Oct 23, 2026▼ -1.1%today
Strata Critical Medical Schedules Third Quarter 2026 Earnings Conference Call
Strata Critical Medical will release its third quarter financial results on November 3, 2026. The earnings call will be hosted by Co-CEOs Melissa Tomkiel and Will Heyburn at 8:00 am ET. Participants can register for the call and access a webcast on the company's website.
Read more →-SRTA
Sep 8, 2026Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference
Strata Critical Medical, Inc. will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 14, 2026. The company focuses on logistics solutions for healthcare providers and is expanding its services through acquisitions. A webcast of the event will be available for interested parties.
Read more →-SRTA
Aug 4, 2026Strata Critical Medical Announces Second Quarter 2026 Results
Strata Critical Medical reported a 60.7% revenue increase to $72.5 million for Q2 2026, driven by strong performance in its Clinical segment. Adjusted EBITDA reached $7.9 million, reflecting improved margins. However, the company faced a net loss of $(10.5) million due to accelerated trademark amortization and reduced logistics profitability. The firm completed multiple acquisitions to enhance its service offerings.
Read more →-SRTA
Jul 21, 2026Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
Strata Critical Medical will release its second quarter 2026 financial results on August 4, 2026. A conference call will follow at 8:00 am ET, hosted by Co-CEOs Melissa Tomkiel and Will Heyburn. Participants can register for the call and access a webcast through the company's website.
Read more →-SRTA
Jun 24, 2026Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
Strata Critical Medical, Inc. has acquired the Heart and Lung Transplant National Recovery Program for $21.5 million. This acquisition enhances Strata's organ recovery platform by increasing the availability of experienced transplant surgeons across key markets. The deal is expected to improve service delivery and operational efficiency in transplant surgeries.
Read more →-SRTA
Jun 2, 2026Strata Acquires Louisville Perfusion Services
Strata Critical Medical, Inc. has acquired Louisville Perfusion Services, enhancing its capabilities in cardiac surgery and organ transplant support. The $16 million all-cash deal aims to strengthen Strata's presence in Kentucky and Ohio, with LPS expected to generate approximately $10 million in revenue for 2026. This acquisition is part of Strata's strategy to grow through targeted acquisitions.
Read more →-SRTA
May 7, 2026Strata Critical Medical Announces Expiration of Warrants
Strata Critical Medical, Inc. announced the expiration of its Public and Private Placement Warrants on May 7, 2026. This expiration occurred in accordance with the original terms set for these financial instruments. Strata operates a significant logistics and medical services network in the U.S. healthcare sector, focusing on transplant services.
Read more →-SRTA
May 6, 2026▲ +10.6%on this newsshared move
Strata Critical Medical Announces First Quarter 2026 Results
Strata Critical Medical reported a strong financial performance for Q1 2026, with revenues rising 87.4% year-over-year to $67.4 million. The company experienced notable growth in both logistics and clinical segments, alongside the successful acquisition of Ohio Valley Perfusion Associates. Despite some challenges, including a slight decline in logistics revenue due to external factors, Strata remains optimistic about its growth trajectory and operational improvements.
Read more →-SRTA
Apr 30, 2026Strata Acquires Ohio Valley Perfusion Associates
Strata Critical Medical, Inc. has acquired Ohio Valley Perfusion Associates, enhancing its presence in Eastern Ohio and Western Pennsylvania. This acquisition allows Strata to leverage its team of perfusionists and expand advanced services like ECMO support. The deal, valued at about $1 million, aligns with Strata's growth strategy in the cardiac perfusion market.
Read more →-SRTA
Apr 20, 2026▲ +6%on this news
Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
Strata Critical Medical will announce its financial results for Q1 2026 on May 6, 2026. A conference call will follow at 8:00 am ET, hosted by Co-CEOs Melissa Tomkiel and Will Heyburn. Participants can register for the call and access a replay of the webcast for one year.
Read more →-SRTA
Apr 9, 2026Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
Strata Critical Medical announced its participation in the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026. The presentation will be accessible via a webcast, with a replay available afterward. Strata focuses on logistics solutions for healthcare providers and has a subsidiary specializing in organ transportation.
Read more →-SRTA
Feb 5, 2026▼ -6.2%on this news
Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution
Strata Critical Medical, Inc. has announced the closing of a $30 million revolving credit facility with JPMorgan Chase Bank to support its acquisition strategy. This facility can be increased to $50 million under certain conditions, providing the company with enhanced capital efficiency for future acquisitions. Moreover, Strata's owned aircraft will remain unencumbered, yielding options for additional financing. The company aims to leverage its proven acquisition strategy to further accelerate growth in the medical logistics sector.
Read more →-SRTA
Dec 3, 2025▲ +6.2%on this news
Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors
Strata Critical Medical, Inc. has appointed Will Cook to its Board of Directors as of December 2, 2025. Cook, who is the President and CEO of Vail Health, will also serve on the Compensation and Nominating and Corporate Governance Committees. His extensive experience in healthcare, including leadership roles at University of Colorado Hospital and UPMC, is expected to bolster Strata's mission to enhance organ recovery services across the United States. The announcement highlights Strata's focus on expanding its logistics and medical services in the organ transplant industry.
Read more →-SRTA
Aug 29, 2025STRATA CRITICAL MEDICAL, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Overview On
STRATA Critical Medical, Inc. completed the sale of its Passenger business to Joby Aero, Inc. for approximately $76 million. This transaction signifies a strategic shift in the company's operations, with the Passenger business now classified as discontinued. Additionally, there is potential for an earnout of up to $35 million based on future performance. Nevertheless, the financial statements indicate that the company faced considerable losses prior to the sale, raising concerns about its financial health going forward.
Read more →-SRTA
Aug 4, 2025Blade announces sale of Passenger Division to Joby, to Pure-Play Medical Services and Logistics Business
Blade Air Mobility has announced the sale of its passenger division to Joby Aviation for up to $125 million, allowing the company to focus exclusively on its medical services and logistics business. Post-transaction, Blade will rebrand as Strata Critical Medical and aims to provide critical healthcare logistics through partnerships and acquisitions. The deal is expected to be EBITDA neutral and will enable Strata to leverage Joby's aircraft for medical use, enhancing its capabilities. This transition aligns with Blade's long-term mission to promote electric aircraft solutions while emphasizing their commitment to healthcare logistics.
Read more →-SRTA
Feb 13, 2023hereto and is incorporated by reference herein. (d) Exhibits. Exhibit No. Description 2.1 + Agreement and Plan of Merger, dated as of
Blade Air Mobility, Inc. has petitioned the Delaware Court of Chancery for relief under 8 Del. C. 205, seeking validation of its potentially defective corporate acts. The petition concerns the adoption of a New Certificate of Incorporation linked to its merger with BLADE Urban Air Mobility, Inc., particularly regarding an amendment that increased shares of Class A Common Stock. The need for this petition arises from doubts about the Class A Increase Amendment's legality, stemming from a recent court ruling that questioned whether Class A shares required a separate vote. Consequently, the company is at risk of facing significant operational disruptions.
Read more →-SRTA
May 19, 2022Blade to Acquire Three Urban Air Mobility Companies Creating Largest Helicopter Passenger Service in Europe Acquisition will roll up the charter and scheduled air mobility businesses of Monacair, H li S curit and a third
Blade to Acquire Three Urban Air Mobility Companies Creating Largest Helicopter Passenger Service in Europe YORK (May 19, 2022) - Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade") a technology-powered global air mobility platform, today announced that it has entered into a defi
Read more →-SRTA
Dec 2, 2021BLADE ACQUIRES EXCLUSIVE RIGHTS TO HELIJET'S SCHEDULED PASSENGER BUSINESS IN CANADA; FLIGHTS WILL CONTINUE TO UTILIZE HELIJET OWNED AND OPERATED AIRCRAFT Acquisition brings Helijet's scheduled air mobility business, whic
BLADE ACQUIRES EXCLUSIVE RIGHTS TO HELIJET'S SCHEDULED PASSENGER BUSINESS IN CANADA; FLIGHTS WILL CONTINUE TO UTILIZE HELIJET OWNED AND OPERATED AIRCRAFT New York, NY and Vancouver, BC, Canada (December 2, 2021) - Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company
Read more →-SRTA
Sep 24, 2021Blade Air Mobility Appoints Reggie Love to Board of Directors Replacing David Zaslav New York, NY (
Blade Air Mobility Appoints Reggie Love to Board of Directors Replacing David Zaslav New York, NY (September 24, 2021) - The Board of Directors (the "Board") of Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company"), a technology-powered global air mobility platfor
Read more →-SRTA
Sep 17, 2021BLADE AIR MOBILITY COMPLETES ACQUISITION OF TRINITY AIR MEDICAL, INC. New York, NY and Phoenix, AZ (
BLADE AIR MOBILITY COMPLETES ACQUISITION OF TRINITY AIR MEDICAL, INC. New York, NY and Phoenix, AZ (September 17, 2021) - Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company"), a technology-powered global air mobility platform, today announced the completion of th
Read more →About Strata Critical Medical, Inc. Class A Common Stock
Headquarters666 THIRD AVENUE, NEW YORK, NY, 10017
BIOPHARMAWATCH ELITE PLUS
Trade the next SRTA catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime